IFNA1 and neoplasm: For example, ADAR1 promotes tumor progression in melanoma and TNBC by evading the immune system and suppressing IFN signaling (292, 293), while ADAR2 exhibits tumor-suppressive roles in GBM and liver cancer by editing transcripts such as COPA and CDC14B (97).